One Daily Multivitamin Slowed Biological Aging by About 4 Months Over 2 Years
The health value of multivitamins has been debated for decades, with critics calling them expensive urine and advocates framing them as nutritional insurance. The COSMOS research team has published new data in Nature Medicine that shifts this conversation toward measurable biology.
Trial Design
The COSMOS (Cocoa Supplement Multivitamins Outcomes Study) trial randomized 958 healthy adults, average age 70 (482 women, 476 men), to receive either a daily multivitamin-mineral supplement (Centrum Silver) or placebo for two years. A separate arm also evaluated cocoa extract.
Biological age was assessed through DNA methylation patterns in blood samples, analyzed across five epigenetic clocks, mathematical models that estimate how fast your cells are aging regardless of your birth date.
Core Findings
The multivitamin group showed approximately 4 months (range: 2.7 to 5.1 months) less biological aging over two years compared to placebo.
Of the five clocks tested, two with the strongest mortality-prediction track records, PCGrimAge and PCPhenoAge, showed statistically significant deceleration. The remaining three (Horvath, Hannum, and DunedinPACE) did not reach significance.
Critically, participants who entered the trial with accelerated biological aging, meaning their epigenetic age exceeded their chronological age, experienced the largest benefit.
What Epigenetic Clocks Measure
DNA methylation is a chemical modification that regulates gene activity. As we age, methylation patterns at specific genomic locations change predictably. Epigenetic clocks quantify this drift into a single number: your biological age.
Second-generation clocks like PCGrimAge and PCPhenoAge go further. They incorporate physiological markers associated with actual mortality risk, not just chronological correlation. When these clocks slow down, it suggests the metabolic and inflammatory processes tied to aging are genuinely decelerating.
Why 4 Months Matters
Four months may sound modest for a two-year intervention. But consider the context: this is a widely available, inexpensive supplement with a well-established safety profile. Senior author Howard Sesso of Harvard and Mass General Brigham noted that understanding even incremental benefits of multivitamins improves the foundation for evidence-based recommendations.
No single supplement is a longevity intervention. But if baseline nutrient sufficiency, delivered through a balanced multivitamin, measurably slows epigenetic drift, it reinforces the principle that consistent, unglamorous habits often outperform targeted interventions.
If You Already Take a Multivitamin
This study does not require any action change for current users. For those who have been on the fence, it adds one more data point favoring daily use. The caveat remains: high-dose single vitamins (such as vitamin A or vitamin E alone) can be harmful in excess. The benefit observed here was from a balanced, moderate-dose combination.
Frequently Asked Questions
Which multivitamin was used in the study? The COSMOS trial used Centrum Silver. Whether the same results apply to every multivitamin brand remains unconfirmed. The key principle is that a comprehensive vitamin-mineral combination influenced epigenetic aging clocks.
Is 4 months of slowed aging clinically meaningful? At the individual level, 4 months is hard to feel. At a population level, 2.7-5.1 months of decelerated biological aging from a low-cost, low-risk intervention is substantial. Shifted across millions of people, it could delay the onset of chronic diseases.
Does this apply to younger adults? The average participant was 70 years old, and the greatest benefit appeared in those whose biological age exceeded their chronological age at baseline. Data on younger, healthy adults is currently lacking.